Conference item icon

Conference item

Insulin therapy in type II diabetes.

Abstract:

When diet therapy is no longer effective in keeping the fasting plasma glucose level < 6 mmol l-1, a basal insulin supplement from a long-acting insulin such as ultralente can be added instead of using a sulphonylurea or metformin. The dose of insulin required can be predicted from the level of the fasting plasma glucose and the degree of obesity, which provides an index of the accompanying insulin resistance. The risk of hypoglycaemia is minimal provided that the dose is adjusted accordin...

Expand abstract
Publication status:
Published

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
RDM
Sub department:
OCDEM
Role:
Author
Journal:
Diabetes research and clinical practice
Volume:
28 Suppl
Pages:
S179-S184
Publication date:
1995-08-01
Event title:
Hoechst Satellite Symposium on New Oral Antidiabetic Agents - From Today to Tomorrow, at the 15th International-Diabetes-Federation Congress
DOI:
EISSN:
1872-8227
ISSN:
0168-8227
Source identifiers:
22150
Keywords:
Pubs id:
pubs:22150
UUID:
uuid:6256fea9-713b-44b8-9baf-e6ea1647252a
Local pid:
pubs:22150
Deposit date:
2012-12-19

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP